Southern Oncology Specialists

Charlotte, North Carolina 28262

0 studies enrolling now · 2 studies all time

What they study most

BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Neoplasms, Febrile Neutropenia, Non-myeloid Malignancy

Studies at this site

• A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) — Completed
• An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca — Status unconfirmed